Bacteria: Exploring new horizons

Streptomyces bacteria employ a newly-discovered cell type, the "explorer" cell, to rapidly colonize new areas in the face of competition.
  1. Vineetha M Zacharia
  2. Matthew F Traxler  Is a corresponding author
  1. University of California, Berkeley, United States

Historically, bacteria have been thought of as simple cells whose only aim is to replicate. However, research over the past two decades has revealed that many types of bacteria are able to develop into communities that contain several types of cells, with different cell types performing particular roles (Kuchina et al., 2011). These communities are of interest in scientific fields as diverse as petroleum engineering and bacterial pathogenesis.

Streptomyces were perhaps the first bacteria to be recognized as having a multicellular lifestyle (Waksman and Henrici, 1943). In fact, this lifestyle led to them being classified as fungi when they were first isolated from soil at the beginning of the last century (Hopwood, 2007). This case of mistaken identity stemmed from the fuzzy texture of Streptomyces colonies (see Figure 1A), which resembles many of the fungi we see growing on bread and other natural surfaces (Waksman, 1954).

The multicellular lifestyle of Streptomyces

Streptomyces bacteria form colonies that contain several different types of specialized cells: vegetative hyphae, aerial hyphae, spores and the "explorer" cells discovered by Jones et al. (A) A Streptomyces coelicolor colony exhibiting aerial hyphae (white) and spores (gray). The blue droplets contain compounds that are naturally produced by S. coelicolor including antibiotics. (B) Streptomyces venezuelae explorer cells spreading on a rock. (C) In addition to these four types of cells, it is possible that Streptomyces colonies might contain other cell types that produce specialized metabolites, such as antibiotics, signaling molecules or volatile organic compounds (VOCs). 

Image credits: panel A and C Vineetha Zacharia; panel B Jones et al. (2016)

The first stage in the life of a Streptomyces colony is the growth of so-called vegetative cells, which form networks of branched filaments that penetrate the surfaces of food sources. The fuzzy appearance of Streptomyces colonies is the result of the vegetative cells producing another type of cell called aerial hyphae that grow upwards into the air (McCormick and Flärdh, 2012; Flärdh and Buttner 2009). Subsequently, cells of a third type (spores) form long chains on the ends of these aerial hyphae. These spores are resistant to drying out and likely allow Streptomyces to passively spread to new environments through the action of water or air movement (McCormick and Flärdh, 2012). Now, in eLife, Marie Elliot at McMaster University and colleagues – including Stephanie Jones as first author – report a new form of growth in Streptomyces termed “exploratory growth” (Jones et al., 2016).

In the initial experiments, Jones et al. – who are based at McMaster University, the University of Toronto and Dartmouth College – grew Streptomyces venezuelae bacteria alone, or close to a yeast called Saccharomyces cerevisiae, on solid agar for two weeks. During this time, the bacteria grown alone formed a normal sized colony typical of Streptomyces. However, in the presence of the yeast, the S. venezuelae colonies expanded rapidly and colonized the entire surface of the growth dish, engulfing the nearby yeast colony. In subsequent experiments, the cells produced during exploratory growth (dubbed “explorer” cells) showed the ability to spread over abiotic surfaces including rocks (Figure 1B) and polystyrene barriers. Scanning electron microscopy revealed that, unlike vegetative cells, these explorer cells did not form branches and more closely resembled simple aerial hyphae.

Previous studies have identified many genes that regulate the development of Streptomyces colonies including the bld genes, which are involved in the formation of aerial hyphae, and the whi genes, which are required to make spores (McCormick and Flärdh, 2012). Jones et al. found that neither of these sets of genes are required for exploratory growth of S. venezuelae in the presence of the yeast. This suggests that the explorer cell type is distinct from the previously known developmental pathways in Streptomyces. Furthermore, Jones et al. found that multiple Streptomyces species were capable of exploratory growth and that various fungal microbes had the ability to trigger this behavior.

Further experiments using libraries of mutant yeast indicated that glucose and pH may be involved in triggering the formation of explorer cells. Jones et al. demonstrated that Streptomyces displays exploratory growth in response to shortages of glucose (caused by the presence of the yeast) and to an increased pH in the surrounding environment. The bacteria trigger this pH change themselves by releasing a volatile organic compound called trimethylamine, which is able to stimulate exploratory growth in Streptomyces over considerable distances. Trimethylamine also inhibits the growth of other bacteria that might compete with S. venezuelae in natural environments.

The work of Jones et al. opens up the possibility that there may be additional types of specialized cells within Streptomyces colonies. Streptomyces are important for medicine because they produce many different chemical compounds, including antibiotics and immunosuppressant drugs, and one might imagine that specific groups of cells within a colony are responsible for making these compounds (Figure 1C). Perhaps other cell types might be dedicated to directing the activities of different cells within the colony (as happens in other bacteria with multicellular lifestyles; Lopez et al., 2009; Baker, 1994), perhaps by producing trimethylamine or other volatile organic compounds.

For decades, researchers have described Streptomyces colonies in terms of vegetative cells, aerial hyphae and spores. The explorer cells identified by Jones et al. offer Streptomyces an alternative means of escape from their normal life cycle and local environment in the face of competition. This makes intuitive sense, given that Streptomyces lack the ability to move (“motility”) in the traditional sense (for example, by swimming, gliding or twitching). Taken together, the work of Jones et al. demonstrates a surprisingly dynamic strategy in which a ‘non-motile’ bacterium can use cues from other microbes, long-range signaling, and multicellularity to make a graceful exit when times get tough.

References

  1. Book
    1. Hopwood DA
    (2007)
    Streptomyces in Nature and Medicine: The Antibiotic Makers
    Oxford, New York: Oxford University Press.
    1. Waksman SA
    2. Henrici AT
    (1943)
    The nomenclature and classification of the Actinomycetes
    Journal of Bacteriology 46:337–341.
  2. Book
    1. Waksman SA
    (1954)
    My Life with the Microbes
    New York: Simon and Schuster.

Article and author information

Author details

  1. Vineetha M Zacharia

    Department of Plant and Microbial Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Matthew F Traxler

    Department of Plant and Microbial Biology, University of California, Berkeley, Berkeley, United States
    For correspondence
    mtrax@berkeley.edu
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published: January 4, 2017 (version 1)

Copyright

© 2017, Zacharia et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,722
    Page views
  • 239
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Vineetha M Zacharia
  2. Matthew F Traxler
(2017)
Bacteria: Exploring new horizons
eLife 6:e23624.
https://doi.org/10.7554/eLife.23624

Further reading

    1. Microbiology and Infectious Disease
    Zikai Zhao et al.
    Research Article

    Zika virus (ZIKV) can be transmitted from mother to fetus during pregnancy, causing adverse fetal outcomes. Several studies have indicated that ZIKV can damage the fetal brain directly; however, whether the ZIKV-induced maternal placental injury contributes to adverse fetal outcomes is sparsely defined. Here, we demonstrated that ZIKV causes the pyroptosis of placental cells by activating the executor gasdermin E (GSDME) in vitro and in vivo. Mechanistically, TNF-α release is induced upon the recognition of viral genomic RNA by RIG-I, followed by activation of caspase-8 and caspase-3 to ultimately escalate the GSDME cleavage. Further analyses revealed that the ablation of GSDME or treatment with TNF-α receptor antagonist in ZIKV-infected pregnant mice attenuates placental pyroptosis, which consequently confers protection against adverse fetal outcomes. In conclusion, our study unveils a novel mechanism of ZIKV-induced adverse fetal outcomes via causing placental cell pyroptosis, which provides new clues for developing therapies for ZIKV-associated diseases.

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Liselot Dewachter et al.
    Research Article Updated

    Antibiotic resistance in the important opportunistic human pathogen Streptococcus pneumoniae is on the rise. This is particularly problematic in the case of the β-lactam antibiotic amoxicillin, which is the first-line therapy. It is therefore crucial to uncover targets that would kill or resensitize amoxicillin-resistant pneumococci. To do so, we developed a genome-wide, single-cell based, gene silencing screen using CRISPR interference called sCRilecs-seq (subsets of CRISPR interference libraries extracted by fluorescence activated cell sorting coupled to next generation sequencing). Since amoxicillin affects growth and division, sCRilecs-seq was used to identify targets that are responsible for maintaining proper cell size. Our screen revealed that downregulation of the mevalonate pathway leads to extensive cell elongation. Further investigation into this phenotype indicates that it is caused by a reduced availability of cell wall precursors at the site of cell wall synthesis due to a limitation in the production of undecaprenyl phosphate (Und-P), the lipid carrier that is responsible for transporting these precursors across the cell membrane. The data suggest that, whereas peptidoglycan synthesis continues even with reduced Und-P levels, cell constriction is specifically halted. We successfully exploited this knowledge to create a combination treatment strategy where the FDA-approved drug clomiphene, an inhibitor of Und-P synthesis, is paired up with amoxicillin. Our results show that clomiphene potentiates the antimicrobial activity of amoxicillin and that combination therapy resensitizes amoxicillin-resistant S. pneumoniae. These findings could provide a starting point to develop a solution for the increasing amount of hard-to-treat amoxicillin-resistant pneumococcal infections.